- Tytuł:
- Apalutamid for treatment of nonmetastatic castration-resistant prostate cancer - case study
- Autorzy:
- Sikora-Kupis, Bożena
- Powiązania:
- https://bibliotekanauki.pl/articles/22676707.pdf
- Data publikacji:
- 2023-03-31
- Wydawca:
- Medical Education
- Tematy:
-
non-metastatic castration-resistant prostate cancer
nmCRPC
androgen receptor targeted agents
ARTA
apalutamide
darolutamide
enzalutamide - Opis:
- A special form of prostate cancer is non-metastatic castration-resistant prostate cancer. Patients with this form have rising prostate-specific antigen and castrate testosterone levels, with no radiological findings of metastatic disease on computed tomography and bone scan. The phase III trials demonstrated apalutamide, darolutamide or enzalutamide to be associated with a significantly longer median metastasis-free survival. The featured description presents one case of man with non-metastatic castration-resistant prostate cancer who was treated with apalutamide.
- Źródło:
-
OncoReview; 2023, 13, 1; 6-8
2450-6125 - Pojawia się w:
- OncoReview
- Dostawca treści:
- Biblioteka Nauki
Artykuł